Rubella encephalitis
ICD-10 B06.01 is a billable code used to indicate a diagnosis of rubella encephalitis.
Rubella encephalitis is a rare but serious complication of rubella infection, primarily affecting the central nervous system. It occurs when the rubella virus invades the brain, leading to inflammation and neurological symptoms. Patients may present with fever, headache, seizures, and altered mental status. The condition can develop in individuals who have contracted rubella, particularly in those who are immunocompromised or have not been vaccinated. Diagnosis is typically confirmed through clinical evaluation and serological testing for rubella-specific IgM antibodies. While rubella encephalitis can occur at any age, it is more common in children. The prognosis varies; some patients may recover fully, while others may experience long-term neurological deficits. Vaccination against rubella is crucial in preventing this condition, as the MMR (measles, mumps, rubella) vaccine has significantly reduced the incidence of rubella and its complications, including encephalitis.
Detailed history of vaccination status and clinical symptoms.
Children presenting with fever and neurological symptoms post-rubella infection.
Ensure documentation reflects the timeline of rubella infection and onset of encephalitis.
Comprehensive lab results and clinical findings related to rubella infection.
Adults with a history of rubella presenting with neurological symptoms.
Consider differential diagnoses and document rationale for rubella encephalitis diagnosis.
Used to confirm rubella infection in patients presenting with encephalitis symptoms.
Document the reason for testing and results in the medical record.
Pediatricians should ensure vaccination history is included.
Symptoms include fever, headache, seizures, confusion, and other neurological signs following a rubella infection.
Diagnosis is made through clinical evaluation, serological testing for rubella-specific antibodies, and exclusion of other causes of encephalitis.
Vaccination with the MMR vaccine significantly reduces the incidence of rubella and its complications, including encephalitis.
